A phase II trial of RX 0201 as a second-line therapy in patients with advanced renal cell cancer.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2009
At a glance
- Drugs RX 0201 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- Sponsors Rexahn Pharmaceuticals
- 06 Mar 2006 New trial record.